Telvas 40 mg Tablets (Telmisartan)

Adult dose

Essential hypertension: It is recommended to take 40 mg orally once daily as Telmisartan, which can be effective at 20 mg once daily depending on patient needs. If necessary, the dose may be increased to 80 mg once daily. Reducing cardiovascular disease risk: It is recommended to take 80 mg orally once daily. Patients with liver impairment: Patients with mild to moderate liver impairment should be treated with caution and should not exceed 40 mg once daily.

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so immediate discontinuation is necessary upon confirmation of pregnancy. Individuals who are allergic to this medication or its components, pregnant or nursing women, patients with severe liver impairment or bile excretion issues should not take this medication. Additionally, patients with hereditary angioedema, those with a history of angioedema while taking ACE inhibitors or angiotensin II receptor antagonists, diabetic patients, patients with severe kidney impairment, and those with lactose intolerance should also avoid this medication. Elderly patients, individuals with high potassium levels in the blood, patients with mild to moderate liver impairment, valvular heart disease, ischemic heart disease, gastrointestinal diseases, and renal vascular hypertension should use this medication cautiously and closely follow medical advice. Adverse reactions such as blood pressure drop, dizziness, angioedema, renal dysfunction, liver function abnormalities, and hyperkalemia may occur during treatment; any symptoms should be promptly discussed with a healthcare provider. In particular, immediate treatment is necessary if blood pressure drops too low or if symptoms of shock or fainting occur. Patients with impaired kidney function should have serum potassium and creatinine levels tested regularly, and although patients undergoing dialysis can use this medication without dose adjustments, their condition should be closely monitored. Patients with reduced blood volume or sodium deficiency are at risk of hypotension, so their condition should be corrected before administering this medication. Caution is advised when using this medication with other antihypertensives, as it may enhance blood pressure-lowering effects, and when taken with certain medications, there may be an increased risk of renal dysfunction or hyperkalemia, necessitating consultation with a physician. Pregnant women or those planning to become pregnant should not use this medication, and breastfeeding patients should either avoid it or discontinue nursing. Safety and efficacy have not been confirmed in children under 18, so use is not recommended. Elderly patients should be carefully monitored due to the risk of excessive blood pressure reduction leading to stroke and other complications. In cases of overdose, symptoms such as hypotension, arrhythmia, dizziness, and renal failure may occur, necessitating immediate medical treatment; this medication cannot be removed by dialysis. When stored, keep this medication out of reach of children and do not transfer it to other containers.

Serious side effects

• Hives
• severe swelling (edema)
• chest tightness
• difficulty breathing
• cold sweat
• pallor
• sepsis
• anaphylactic reactions
• angioedema (potentially fatal)
• toxic skin rash

Mild side effects

• Upper respiratory tract infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

Store this medication in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve its effectiveness.

Appearance

White oval-shaped tablet

Package unit

30 tablets (10 tablets/AluAlu*3)